Get the Stockscreener App
24.27
1.54%
-0.3802
Virtus Lifesci Biotech Clinical Trials Etf stock is traded at $24.27, with a volume of 2,385.
It is down -1.54% in the last 24 hours and down -10.39% over the past month.
See More
Previous Close:
$24.65
Open:
$24.81
24h Volume:
2,385
Relative Volume:
0.94
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.15%
1M Performance:
-10.39%
6M Performance:
-7.37%
1Y Performance:
-6.51%
1-Day Range:
$24.26
$24.81
1-Week Range:
$24.26
$25.28
52-Week Range:
$23.51
$31.99
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Company Profile
Name
Virtus Lifesci Biotech Clinical Trials Etf
Sector
Industry
Phone
-
Address
-
Compare BBC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBC
Virtus Lifesci Biotech Clinical Trials Etf
|
24.27 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
291.68 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
589.49 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
592.19 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
242.00 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
515.27 | 124.43B | 0 | 0 | 0 | 0.00 |
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Latest News
7 Best-Performing Biotech ETFs for January 2025 - NerdWallet
When (BBC) Moves Investors should Listen - Stock Traders Daily
(BBC) Proactive Strategies - Stock Traders Daily
(BBC) Long Term Investment Analysis - Stock Traders Daily
How to Take Advantage of moves in (BBC) - Stock Traders Daily
(BBC) Technical Data - Stock Traders Daily
(BBC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
The 5 Best Biotech ETFs of 2024 - TradingView
Capitulation in biotech is near, as well as a rally – Piper Sandler (NYSEARCA:XBI) - Seeking Alpha
(BBC) Trading Signals - Stock Traders Daily
Long Term Trading Analysis for (BBC) - Stock Traders Daily
Viking Therapeutics, Inc. (VKTX): Biotech Breakthrough or Short Sellers’ Target? - Yahoo Finance
Where are the Opportunities in (VABS) - Stock Traders Daily
FYC: Smart Or Speculative Small-Cap Growth ETF? (NASDAQ:FYC) - Seeking Alpha
(BBC) Trading Advice - Stock Traders Daily
Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Trading Up 2% - Defense World
Where are the Opportunities in (BBC) - Stock Traders Daily
The Great Rotation: Just Getting Started? - ETF Trends
(BBC) Technical Pivots with Risk Controls - Stock Traders Daily
Time for Healthcare ETFs? - Yahoo Finance
Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Shares Up 3.1% - Defense World
TSLA-related ETFs among top performing ETFs on a 4-week performance base last week - Seeking Alpha
5 Top ETFs of Last Week - Yahoo Finance
Inflation Cools in June, Triggers Spike in Laggard ETFs - Markets Insider
UK house prices likely to rise modestly this year and into 2025, says Halifax - Yahoo News UK
SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts? - TipRanks
Pharma Stocks Look Cheap. Here's One Way To Invest. - Barchart
Last Week, Virtus LifeSci Biotech Clinical Trials ETF Climbed 10%. Why? - Opto RoW
This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag - MarketWatch
ETFs to Play Biden's 2024 Reelection Campaign Launch - Nasdaq
Innovation Reigns In 10 Best-Performing ETFs Of The Last 3 Months - FA Mag
Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics - ETF Trends
5 ETFs Riding High on the Biotech Comeback - Yahoo Finance
Best Performing ETFs For June 2022 - TheStreet
Biotech ETF Tops in June: 5 Stocks That Outperform - Yahoo Finance
Betting on Biotech Bear Market Expiration Date - ETF Trends
How to Pick a Biotech ETF - Investment U
Best & Worst Performing ETFs Of 2022 - Yahoo Finance
Biotech ETFs That Outperformed Last Week - Yahoo Finance
Biotech Ready to Participate in Healthcare Bullishness - Nasdaq
Drug Price Debate Might Not Hinder Biotech ETFs - ETFdb.com
Size Up SBIO Ahead of Biotech Rebound - ETF Trends
Finding Synergy With SPY - etf.com
Healthcare ETFs Surge on FDA Full-Vaccine Nod & Deal News - Yahoo Finance
After AstraZeneca, Oxford Nanopore Might Be The Next UK COVID Winner - Investing.com UK
A Healthcare ETF Review: Biotech Beckons under Biden - ETF Trends
More than Just COVID: Hot ETFs for Medical Breakthroughs - ETF Trends
For 2021 Upside, Bet on the SBIO Biotech ETF - ETF Trends
Top Tech ETFs Right Now - Benzinga
ETF of the Week: iShares MSCI China ETF (MCHI) - ETF Trends
ETF of the Week: Vanguard Total Stock Market ETF (VTI) - ETF Trends
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Financials Data
There is no financial data for Virtus Lifesci Biotech Clinical Trials Etf (BBC). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.09%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):